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Abstract 
Competitive binding assays based on the lectin Concanavalin A (ConA) have displayed significant 
potential to serve in continuous glucose monitoring applications.  However, to date, this type of 
fluorescent, affinity-based assay has yet to show the stable, glucose predictive capabilities that are 
required for such an application.  This instability has been associated with the extensive crosslinking 
between traditionally-used fluorescent ligands (presenting multiple low-affinity moieties) and ConA 
(presenting multiple binding sites) in free solution.  The work herein introduces the design and synthesis 
of a new type of fluorescent ligand that can avoid this aggregation and allow the assay to be sensitive 
across the physiologically relevant glucose concentration range.  This fluorescent ligand (APTS-MT) 
presents a single high-ĂĨĨŝŶŝƚǇ ƚƌŝŵĂŶŶŽƐĞ ŵŽŝĞƚǇ ƚŚĂƚ ŝƐ ƌĞĐŽŐŶŝǌĞĚ ďǇ ŽŶ ?Ɛ ĨƵůů ďŝŶĚŝŶŐ ƐŝƚĞ and a 
fluorophore that can effectively track ƚŚĞůŝŐĂŶĚ ?Ɛ equilibrium binding via fluorescent anisotropy.  This is 
confirmed by comparing its measured fluorescent lifetime to experimentally-determined rotational 
correlation lifetimes of the free and bound populations.  Using an assay comprised of 200 nM APTS-MT 
and 1 µM ConA, the fluorescence anisotropy capably tracks the concentration of monosaccharides that 
are known to bŝŶĚ ƚŽ ŽŶ ?Ɛ ƉƌŝŵĂƌǇ ďŝŶĚŝŶŐ ƐŝƚĞ ? ĂŶĚ ƚŚĞ ĂƐƐĂǇ ĚŝƐƉůĂǇƐĂ DZ ŽĨ  ? ? ?A? ĂĐƌŽƐƐ
physiologically relevant glucose concentrations.  Ultimately, this rationally-designed fluorescent ligand 
can facilitate the realization of the full potential of ConA-based glucose sensing assays and provide the 
basis for a new set of competing ligands to be paired with ConA. 
 
Introduction 
Concanavalin A (ConA) is a tetrameric lectin at physiological pH (pH 7.4) with four identical and 
independent subunits that each have a single, primary binding site for glucose or mannose (Bittiger and 
Schnebli 1976).  In 1982, Schulz et al. introduced a fluorescence-based glucose sensing strategy using 
ConA as the receptor (Schultz et al., 1982).  By pairing the lectin with a fluorescent ligand to which it 
would bind, they generated a homogeneous, competitive binding assay that was sensitive to 
physiologically relevant glucose concentrations. This non-consuming fluorescence assay has the 
potential to be used in continuous glucose monitoring devices to track the glucose concentrations of the 
interstitial fluid and offers advantages over traditional enzyme-based sensors when properly tuned 
(Pickup et al., 2005).  This significant potential has led to many variations in the design of the fluorescent 
competing ligands (Ibey et al., 2005; Liao et al., 2008; Tolosa et al., 1997b), optical transduction 
mechanisms (Barone and Strano 2009; Cummins and Coté 2012; Tang et al., 2008), and encapsulation 
techniques used with this assay (Ballerstadt and Schultz 2000; Cummins et al., 2011; Russell et al., 1999). 
However, groups have continued to report aggregate formation caused by extensive crosslinking 
between the traditionally-used fluorescent ligands (presenting multiple low-affinity moieties) and ConA 
(presenting multiple binding sites), resulting in a lack of reversibility of the assay in free solution (Ehwald 
et al., 1996; McCartney et al., 2001; Tolosa et al., 1997a). This aggregation problem has limited the 
utility of ConA-based assays and has proved difficult to overcome with traditional approaches.   
The use of fluorescence anisotropy as a tool to track the glucose-dependent equilibrium binding of a 
ConA-based competitive binding assay and its complete mathematical description was recently 
introduced by our group (Cummins et al., 2013b).  Briefly, the fluorescence anisotropy of a sample 
describes the relationship between the average rate at which fluorescence occurs upon excitation 
(fluorescence lifetime) and the average rate at which the fluorescent molecules are tumbling (rotational 
correlation lifetime).  It can be useful in competitive assay development because it only requires a single 
component to be fluorescently labeled and the anisotropy is independent of the intensity.  Therefore, 
such an approach can avoid problems with spectral bleed-through and photo-bleaching, respectively.  
Ultimately, the sensitivity of a competitive binding assay that only allows the fluorescent ligand to be in 
two populations (bound and free) can be described using Equation 1.   
 
     
οழ࢘வοࡳ ൌ ሺ࢘࢈ െ ࢘ࢌሻ οΨ࡯ࡸ࡮οࡳ    Equation 1  
 
In this equation ο൏ ݎ ൐Ȁοܩ term is the change in the measured anisotropy for a given change in the 
glucose concentration. The anisotropies of the bound and free fluorescent ligand are rb and rf, 
respectively, and their difference is related to the transduction mechanism.  The %CLB is the amount of 
the fluorescent competing ligand that is bound to ConA, which is equivalent to the fractional 
fluorescence intensity coming from the bound population if the quantum yield of the fluorescent ligand 
does not change upon binding to the receptor.  The ሺοΨܥܮܤሻȀοܩ term is the change in the percent 
competing ligand that is bound for a given change in glucose concentrations and is related to the 
recognition mechanism.  Equation 2 shows that the recognition mechanism and the transduction 
mechanism must both be optimized to generate a sensitive assay.   This work identified the assay 
characteristics that maximized the change in the measured anisotropy in response to a change in 
glucose concentration from 0 mg/dL to 300 mg/dL.   
Our previous work used the exact solution to the governing competitive binding equations to identify 
the concentrations that maximize the recognition mechanism of the ConA competitive binding assay for 
a given fluorescent competing ligand (Cummins et al., 2013b).  That model showed that the affinity of 
ConA to 4 kDa dextran (Ka = 5,000 M
-1
) requires a ConA concentration that is higher than its solubility 
limit to maximize the recognition mechanism of the assay.  Therefore, this ligand does not allow the 
maximum change in equilibrium binding to occur over physiological glucose concentrations.  To, instead, 
identify competing ligands that fully realize the sensitivity potential of the assay, the concentration of 
the competing ligand can be fixed (here, it is fixed at 200 nM) and the ConA concentration as well as the 
affinity to the competing ligand can be varied to generate a 2D sensitivity map for the recognition 
mechanism.  Figure 1A displays the interplay between the competing ligand chosen and the ConA 
concentration required for physiological glucose concentrations to be recognized by the assay. 
A similar sensitivity map can be generated for the transduction mechanism by modeling the expected 
change in the steady-state fluorescence anisotropy of fluorescent competing ligands upon their binding 
to ConA.  By assuming that the free competing ligand and bound competing ligand are both spherical 
and rigid, the anisotropy can be predicted as a function of its fluorescent lifetime and molecular weight.  
The differences in these predicted anisotropy values are shown in Figure 1B as a function of these 
variables, where it is assumed that the intrinsic anisotropy (r0) of the fluorophore is the theoretical 
maximum, 0.4.  Lower intrinsic anisotropies would change the scale of the color map but display the 
same profile.  Together, these 2D sensitivity maps identify the assay characteristics required for a ConA-
based competitive binding assay to track physiological glucose concentrations. 
 
 
Figure 1: 2D sensitivity maps of the (A) recognition mechanism and the (B) transduction mechanism, where the red regions 
display the highest sensitivity.    
 
Figure 1A shows that the use of higher-affinity competing ligands requires lower ConA concentrations to 
achieve the maximum possible recognition ƐĞŶƐŝƚŝǀŝƚǇ ?  /ŶĨĂĐƚ ?ƚŚĞĐŽŵƉĞƚŝŶŐ ůŝŐĂŶĚ ?ƐĂĨĨŝŶŝƚǇƚŽŶ
needs to be above ~20,000 M
-1
 to allow the required ConA concentration to be under its solubility limit 
(~100 µM) and still achieve maximum sensitivity.  Ideally, the affinity would be somewhere between 10
5
 
M
-1
 to 10
7
 M
-1
.  ĞĐĂƵƐĞ ŽŶ ?Ɛ ĂĨĨŝŶŝƚǇ ƚŽ ŐůƵĐŽƐĞ ŝƐonly ~400 M-1, groups have traditionally used 
fluorescent competing ligands that present many monosaccharides that can bind to the primary binding 
site of ConA to achieve the higher apparent affinities that are required for sensitive assay responses 
(Schultz et al., 1982).  These multivalent competing ligands (dextrans, glycosylated dendrimers, etc) 
increase the apparent affinity to ConA by employing proximity effects.  However, the pairing of 
multivalent ConA with multivalent competing ligands in these assays consistently leads to extensive 
aggregation and assay irreversibility in free solution (Cummins et al., 2013a; Dam and Brewer 2010; 
Gestwicki et al., 2002; Goldstein et al., 1965).  This has been the primary barrier to the realization of a 
stable ConA-based glucose sensor in free solution.  Using traditional approaches, there is a limiting 
tradeoff between needing to achieve higher affinities for the assay to display sensitivity and needing to 
avoid aggregation to maintain reversibility.   
Even if aggregation was somehow avoided, the traditional type of fluorescent competing ligand is not 
ideal for the transduction mechanism of an anisotropy-based assay because higher MWs are typically 
required to achieve these higher-affinities.  This is exemplified by dextran  ? the most commonly used 
competing ligand in these assays  ? which is a branching polymer built of glucose subunits.  As the MW of 
dextran increases, it presents a higher number of termini that ConA can bind which increases the 
apparent affinity.  One commonly used fluorescent ligand in ConA-based assays is 70 kDa FITC-dextran, 
but this ligand still only displays an apparent affinity of ~15,000 M
-1
 to ConA (Schultz et al., 1982).  
According to the 2D sensitivity map for the transduction mechanism of a fluorescence anisotropy assay 
 ?&ŝŐƵƌĞ  ? ? ? ƚŚĞ ĐŽŵƉĞƚŝŶŐ ůŝŐĂŶĚ ?Ɛ ŵŽůĞĐƵůĂƌ ǁĞŝŐŚƚ ŶĞĞĚƐ ƚŽ ďĞ ĐůŽƐĞƌ ƚŽ  ? ŬĂ ƚŚĂŶ  ? ? ? ŬĂ ?
Ultimately, the ideal characteristics of the fluorescent ligand with regard to the transduction mechanism 
would be a MW of ~1 kDa and a fluorescence lifetime of ~5 ns.     
AĚũĂĐĞŶƚƚŽŽŶ ?ƐƉƌŝŵĂƌǇďŝŶĚŝŶŐƐŝƚĞŝƐĂŶĞǆƚĞŶĚĞĚƉŽĐŬĞƚƚŚĂƚĨĂĐŝůŝƚĂƚĞƐƚŚĞĨŽƌŵĂƚŝŽŶŽĨĂĚĚŝƚŝŽŶĂů
hydrogen bonds to the core trimannose of N-linked glycans. Based on previously reported 
crystallographic data, Figure 2A ƐŚŽǁƐĂĐŽŵƉĂƌŝƐŽŶŽĨŽŶ ?ƐďŝŶĚŝŶŐƚŽƚŚĞŵŽŶŽƐĂĐĐŚĂƌŝĚĞ ?ŵĞƚŚǇů-
ɲ-mannose, with its binding to trimannose (Naismith et al., 1994; Naismith and Field 1996).  The binding 
site for glucose is expected to be the same as for methyl-ɲ-mannose.   These 2D projections show the 
amino acids that form hydrogen bonds with the respective sugars, demonstrating that the full binding 
site of ConA forms hydrogen bonds with each mannose group of trimannose, which should increase the 
affinity without leaving moieties for additional ConAs to bind.  It also shows that trimannose could 
compete with the monosaccharide for binding to a ConA subunit because they both bind to the primary 
binding site. 
  
Figure 2: (A) Comparison between carbohydrate binding to the primary binding site of ConA and the full binding site of ConA, 
using the crystal structures from (Naismith et al., 1994; Naismith and Field 1996).  The black dots represent the amino acids 
capable of forming hydrogen bonds to the hydroxyl groups on the sugar (within 3.5 A of each other).  (B) Schematic of the new 
type of fluorescent ligand that displays (a) a single core trimannose that ConA can recognize and (b) a single fluorophore to 
transduce the equilibrium binding.   
 
Herein, we describe a new type of fluorescent ligand that is rationally-designed to achieve the 
aforementioned, desirable characteristics for the ConA-based glucose sensing assay.  Instead of only 
using the primary binding site of ConA, it is engineered to utilize the full binding site of ConA as depicted 
in Figure 2B.  This rationally-designed fluorescent ligand presents a single high-affinity trimannose 
moiety to achieve the desirable affinity in a manner that avoids the aggregation that has plagued ConA-
based assays.  In addition, the fluorescent ligand is designed to have a molecular weight and fluorescent 
lifetime that can allow the sensitivity of the transduction mechanism to be maximized.  Overall, this 
work has been performed in an attempt to realize the full potential of ConA-based glucose sensing 
assays by offering a new approach to the fluorescent ligand to be paired with ConA. 
 
Materials and Methods 
Materials 
Mannotetraose and trimannose were purchased from V-Labs, Inc (Covington, LA).  Methyl-ɲ-mannose 
(MaM), and 2 MDa dextran were purchased from Sigma (St. Louis, MO).  8-Aminopyrene-1,3,6-
trisulfonic acid, sodium salt (APTS) was provided by Dr. Gyula Vigh (TAMU).  A generation-three 
glycosylated dendrimer (24 terminal amines, 24 terminal glucose residues) was used as provided by Dr. 
Eric Simanek (Texas Christian University, Fort Worth, TX).  All other chemicals were purchased from 
Sigma and used as received.  TRIS buffer was constituted of 10 mM TRIS, 1 M NaCl, 1 mM CaCl2, 1 mM 
MnCl2, at pH 7.4.   
 
Dynamic Light Scattering 
To explore whether the interaction of ConA with a single presentation of the core trimannose leads to 
aggregation in free solution, dynamic light scattering (DLS) measurements were performed.  This 
interaction was compared to the interactions between ConA and other high-affinity ligands that are 
known to aggregate in ConA-based assays.  Dextran, dendrimer and trimannose were added to separate 
cuvettes of ConA solutions and allowed to interact for 12 hours at 22 deg C.  Unlabeled ligands were 
used to compare specific carbohydrate binding achieved by the different approaches.  The final 
concentration was 3 µM for the competing ligand and 3 µM for ConA.  Negative controls were run for 
each competing ligand (3 µM) without ConA present.  ConA was also independently added to a separate 
control cuvette (3 µM).  All solutions were made in TRIS buffer and filtered to remove any particulate 
material before combining the solutions.  After 12 hours, the solutions were mixed with a pipette to 
allow for the re-suspension of any settled material and dynamic light scattering studies were performed.  
The reported data is the average particle size as determined by percent-volume.    
 
Synthesis and Purification 
To synthesize the rationally-designed fluorescent ligand, the following protocol was used.  
Mannotetraose (0.9 mg, 1.35x10
-6
 mol) was mixed with 13.5 ʅ>ŽĨ ?DWd^ ? ? ? ? ?ǆ ? ?-5 mol) prepared in 
15% acetic acid aqueous solution.  dŚĞŶ ? ? ?ʅ>ŽĨ ? ?A?ĂĐĞƚŝĐĂĐŝĚĂƋƵĞŽƵƐƐŽůƵƚŝŽŶǁĂƐĂĚĚĞĚŝŶƚŽƚŚĞ
mixture.  The acidic environment promotes the ring-opening of the reducing terminus of 
mannotetraose.  The reaction mixture was stirred for 5 minutes at room temperature.  dŚĞŶ ? ? ? ? ?ʅ>ŽĨ
1M sodium cyanoborohydride (NaBH3CN, 1.35x10
-5
 mol) in tetrahydrofuran was added into the reaction 
mixture and stirred for 14 hours at room temperature.  Sodium cyanoborohydride is a reducing agent 
that converts the Schiff base into the stable APTS-mannotetraose (APTS-MT) conjugate.  The schematic 
is shown in Figure 3A.   
Following reductive amination, the crude product was purified by hydrophilic interaction liquid 
chromatography (HILIC).  The chromatogram is shown in Figure 3B. The solid line shows the elution 
profile for the reaction mixture of APTS and mannotetraose after reductive amination.  The peak labeled 
A is from unconjugated APTS.  The peak labeled B is from the APTS-MT.  Peak B was collected and the 
collected fraction was again analyzed on the column to show its purity.  The dotted line is the elution 
profile of the purified conjugate.  The inset shows the absorbance profiles of the unconjugated APTS and 
the conjugated APTS.  These, along with the ESI-MS of the purified fraction were used to confirm 
conjugation.   
 
 
 Figure 3: (A) Synthesis of APTS-MT via reductive amination. (B) HILIC chromatograms of the reaction mixture (solid line) and the 
purified APTS-MT (dotted line).  The inset shows the absorbance spectra of APTS (a) and the APTS-MT product (b). 
 
Fluorescent Characterization 
Steady state fluorescence and intrinsic anisotropy measurements were performed on a Fluorolog-3 from 
Horiba Jobin Yvon.  Excitation and emission scans were performed to characterize the fluorescence of 
100 nM APTS-MT in TRIS buffer.  Intrinsic anisotropy was measured by adding APTS-MT in a 50% glycerol 
solution at a concentration of 100 nM and setting the temperature to 5 deg C.  This effectively slowed 
the rotation of the fluorescent molecules in the excited state to negligible amounts, which insures that 
the steady-state anisotropy value is essentially the intrinsic anisotropy.  Ten measurements were taken 
for each sample; the recorded anisotropy value is the average of those measurements.   
The fluorescence lifetime and dynamic anisotropy data were collected using a DeltaFlex time correlated 
single photon counting system from Horiba that was equipped with a 482 nm DeltaDiode pulsed source.  
The effect that ConA binding has on the fluorescence lifetime and rotational correlation lifetime of 
APTS-MT was studied using a solution of 200 nM APTS-MT with and without 1 µM ConA present.  The 
fluorescence intensity decays were analyzed with the Decay Analysis Software (v. 6.6) from Horiba, and 
fits were used according to the expected distribution in the solution. The dynamic anisotropy decays 
were analyzed by using a reconvolution algorithm to determine the best-fit rotational correlation 
lifetimes.   
 
Binding Studies 
Binding studies were carried out with a filter-based fluorescence microplate reader that was equipped 
with polarizers and the appropriate fluorescence filters for conjugated APTS.  A microplate was loaded 
with serial dilutions of ConA and the same concentration of APTS-MT (200 nM).  Solutions in the plate 
were allowed to reach equilibrium at room temperature (22 deg C), and scans were performed in the 
perpendicular and parallel directions.  Background values were subtracted from each measurement.  
The G-factor was determined by setting the fluorescence anisotropy of free APTS-trimannose at a value 
of 0.03, and this G-factor was used to calculate the anisotropy of each well.   
Using the results from the modeled assay, the concentrations for the binding assay were chosen to be 
200 nM APTS-MT and 1 µM unlabeled ConA.  Following a similar strategy as the affinity-binding studies 
between APTS-MT and ConA, microplate wells were loaded with this assay for varying concentrations of 
methyl-ɲ-mannose, glucose, and galactose from ~0.2 mg/dL to ~10,000 mg/dL.  The assay was given an 
appropriate time to reach equilibrium at room temperature (22 deg C) and steady state anisotropy was 
measured using the filter-based fluorescence microplate reader.  This assay configuration was exposed 
ƚŽĂĚĚŝƚŝŽŶĂůŐůƵĐŽƐĞĐŽŶĐĞŶƚƌĂƚŝŽŶƐ ŝŶ ƚŚĞƉŚǇƐŝŽůŽŐŝĐĂů ƌĂŶŐĞ ? dŽĐŽŵƉĂƌĞ ƚŚĞĂƐƐĂǇ ?ƐƉĞƌĨŽƌŵĂŶĐĞ
ǁŝƚŚ ƚŚĞ  ‘ŐŽůĚ ƐƚĂŶĚĂƌĚ ? ? ƚŚĞ ĂĐƚƵĂů ŐůƵĐŽƐĞ ĐŽŶĐĞŶƚƌĂƚŝŽŶƐ ǁĞƌĞ ĚĞƚĞƌŵŝŶĞĚ ŽŶ Ă z^/ ďŝŽĐŚĞŵŝƐƚƌy 
analyzer.  These anisotropy values were used to generate a calibration fit via the typical competitive 
binding equation, and this equation was used to predict the glucose concentrations.  
 
Results and Discussion 
Dynamic Light Scattering 
The primary problem that has plagued ConA-based glucose sensing assays is the tradeoff between 
needing a high-affinity competing ligand for sensitivity and needing to avoid the extensive crosslinking 
between the high-affinity competing ligand and ConA in free solution.  This aggregation changes the 
binding kinetics in an assay and results in a different response to physiologically relevant glucose 
concentrations over time.  Figure 4A ĐŽŵƉĂƌĞƐ ŽŶ ?Ɛ ŝŶƚĞƌĂĐƚŝŽŶ ǁŝƚŚ ƚƌĂĚŝƚŝŽŶĂů ĐŽŵƉĞƚŝŶŐ ůŝŐĂŶĚƐ
that achieve the higher affinity by presenting many low-affinity moieties to ConA with the proposed 
competing ligand that presents a single high-affinity moiety.  The particle-size data from the DLS 
measurements highlights the potential utility of trimannose to overcome the aforementioned tradeoff.  
It can be seen that the average size of the particles is much larger for the traditional ligands, indicating 
that ConA and these ligands have already formed extensive aggregates after only 12 hours.  In 
comparison, the average size of particles in the solution that contains trimannose and ConA has not 
increased, indicating that, if binding occurred, trimannose did not lead to significant aggregation.    
 
Synthesis and Purification 
To achieve the ideal characteristics as identified by the 2D sensitivity maps, the goal was to engineer a 
fluorescent ligand in a manner that displayed a fully-preserved trimannose group and a single 
fluorophore.  Therefore, the commonly used periodate oxidation method to generate carbonyl groups 
on a polysaccharide for fluorophore attachment was not appropriate (Bobbitt 1956). This would destroy 
ƚŚĞ ŵĂŶŶŽƐĞ ŵŽŝĞƚŝĞƐ ƌĞƋƵŝƌĞĚ ĨŽƌ ďŝŶĚŝŶŐ ƚŽ ŽŶ ?Ɛ ĨƵůů ďŝŶĚŝŶŐ ƐŝƚĞ ĂŶĚ ĐŽƵůĚ ŝŶƚƌoduce several 
fluorophores to a single glycan.  Reductive amination, on the other hand, is a more controlled method 
that has been used to label glycans for subsequent chromatographic or electrophoretic separation and 
identification of the glycans (Bigge et al., 1995; Guttman et al., 1996; Harvey 2000; Sato et al., 1998).  By 
using an amine-bearing fluorophore, this method introduces a single label at the reducing terminus of 
the glycan.  This causes the reducing sugar of the glycan to be acyclic but leaves the remaining sugars of 
the glycan in their cyclic, unaltered form to be recognized by receptors (Leteux et al., 1998).  Thus, the 
trimannose moiety-bearing mannotetraose was used to maintain the trimannose structure after 
conjugation. 8-Aminopyrene-1,3,6-trisulfonic acid (APTS) was chosen as the amine-bearing fluorophore 
to attach to mannotetraose.  APTS is a water-soluble fluorophore whose fluorescence is independent of 
pH over a wide range.  It has been used to label populations of glycans enzymatically cleaved from 
glycoproteins to facilitate their separation via capillary electrophoresis due to its three negative charges 
per fluorophore at neutral pH (Guttman et al., 1996).  ĞĐĂƵƐĞ ŽŶ ?Ɛ ŝƐŽĞůĞĐƚƌŝĐ ƉŽŝŶƚ ŝƐ ĂƌŽƵŶĚ  ? ?
these negative charges also minimize non-specific electrostatic interactions between the fluorescent 
ligand and ConA at physiological pH. 
 
 
Figure 4:  (A) Average particle size in solutions of ConA and various ligands where the error bars indicate the standard deviation 
between different samples.  (B) Fluorescence characterization of the purified APTS-MT in TRIS buffer.   
 
Fluorescent Characterization 
The APTS-MT fluorescent ligand that was synthesized is a stable conjugate that presents a single 
trimannose moiety and a single water-soluble fluorophore (MW = 1.1 kDa).  Fluorescence 
characterization of the purified APTS-MT conjugate shows an excitation maximum at ~455 nm and an 
emission maximum at ~518 nm.  This is a red-shift in the excitation and emission spectra compared to 
those of the unconjugated APTS. The fluorophore shows a relatively high Stokes shift of approximately 
60 nm, which allows for a large band of fluorescence wavelengths to be collected to improve detection 
sensitivity without problems arising from scattered excitation light. The intrinsic anisotropy of the APTS-
MT conjugate is relatively constant near the excitation maximum with a value of ~0.30.  The maximum 
possible intrinsic anisotropy is 0.4, and occurs only when the excitation and emission dipoles are in the 
exact orientation.  For comparison, fluorescĞŝŶ ?ƐŝŶƚƌŝŶƐŝĐĂŶŝƐŽƚƌŽƉǇŝƐ ? ? ? ? ? (Jameson and Ross 2010).     
The fluorescence lifetime decay of 200 nM APTS-MT displayed a single exponential decay with a lifetime 
of ~5.3 ns and a F2 value of 1.29.  To determine the effect of ConA binding on the fluorescence lifetime 
of APTS-MT, the fluorescence lifetime decay of 200 nM APTS-MT in the presence of 1 µM ConA was 
measured.  This displayed a single exponential decay with a lifetime of ~5.4 ns and a F2 value of 1.38.  
Since the addition of 1 µM ConA should result in a majority of the APTS-MT being bound to ConA, the 
results indicate that the lifetime does not significantly change upon binding to ConA.  Therefore, the 
assumption that the percent of the fluorescent competing ligand bound is equal to the fluorescence 
intensity from the bound population holds true.  Compared with the 2D sensitivity map of the 
transduction mechanism in Figure 1B, the combination of the experimentally determined fluorescent 
lifetime (5.3 ns) and molecular weight (1.1 kDa) is well-suited to track the ConA binding. 
This change in anisotropy could potentially be increased even further by decreasing the molecular 
weight of the fluorescent ligand or using a fluorophore with a higher intrinsic anisotropy.  However, 
decreasing the molecular weight has practical limitations.  The fluorescent competing ligand must have 
a specific carbohydrate moiety for ConA to bind and a fluorophore to transduce the binding events.  An 
alternative way to increase the sensitivity of the transduction mechanism would be to increase the 
molecular weight of the receptor and use a longer-lifetime fluorophore on the competing ligand.  
Nevertheless, APTS-MT is a significant improvement over previous fluorescent competing ligands and 
can be considered an appropriate fluorescent ligand to maximize the sensitivity of a fluorescence 
anisotropy glucose sensing assay based on native ConA.   
Dynamic anisotropy measurements were performed to determine the actual rate of tumbling for the 
free APTS-MT and the bound APTS-MT.  The reconvolution algorithm for the dynamic anisotropy was 
used to fit the rotational correlation lifetime and the relative amounts in each population.  Without 
ConA present, the fit showed a single rotational correlation lifetime of ~0.6 ns.  This is expected to be 
solely due to APTS-MT.  The fit for the solution with 1 µM ConA present showed two rotational 
correlation lifetimes (0.6 ns and 20 ns) and relative populations that agree with the steady-state titration 
studies in Figure 5A.  This indicates that the rotational correlation lifetime of the bound APTS-MT is 20 
ns. The modeled anisotropy of the free and the bound APTS-MT were 0.5 ns and 48 ns.  The disparity 
between the modeled and experimental values for the bound APTS-MT can be explained by the slight 
motion between APTS-MT and ConA and the non-spherical shape of the bound complex.  
These experimentally-determined rotational correlation lifetimes can be used to further validate the 
suitability of the experimentally-determined fluorescence lifetime of APTS-MT to the actual change in 
tumbling upon binding.  The steady-state anisotropy for each rotational correlation lifetime was 
predicted for the full range of possible fluorescence lifetimes.  The difference between these two curves 
is the expected change in steady-state anisotropy upon binding for any given fluorescence lifetime.  
Using an intrinsic anisotropy of 0.3, the maximum possible change upon binding was 0.19, requiring a 
fluorescence lifetime of 4.5 ns.  The fluorescence lifetimes that displayed greater than 99% of this 
maximum possible change ranged from 3.5 ns to 5.7 ns.   Therefore, the fluorescence lifetime of APTS-
MT (5.3 ns) is shown to be ideal to track this binding event and optimize the transduction mechanism of 
the fluorescence assay. 
 
Binding Studies 
Fluorescence anisotropy was used to determine the binding affinity between APTS-MT and native ConA 
in TRIS buffer at 22 deg C.  The higher ConA concentrations lead to a greater percentage of APTS-MT 
bound to ConA.  This population should tumble at a slower rate, and higher percentages of bound APTS-
MT should increase the overall stead-state anisotropy from the solution.  Assuming the change in 
fluorescence lifetime upon binding to ConA to be negligible, the ConA-dependent anisotropy was 
calculated and shown in Figure 5A.  These results were fit with a Boltzmann curve to determine the 
association constant to be 5.61*10
6 
M
-1
.  This value is significantly higher than what is seen for 
monosaccharides, like glucose, that only exploit the primary binding site (400 M
-1
).  Compared with the 
2D sensitivity map of the recognition mechanism in Figure 1A, this affinity would allow the maximum 
sensitivity of the assay to be reached at ConA concentrations that are well below its solubility limit.   
 
 
Figure 5: (A) Steady-state anisotropy of 200 nM APTS-MT with increasing ConA concentrations on a semi-log plot and the 
calibration fit that shows an affinity of 5.61*10
6 
M
-1
.  (B) Steady-state anisotropy of an assay containing 200 nM-MT and 1 µM 
ConA for a range of concentrations of various monosaccharides on a semi-log plot using the corresponding calibration fits.   
 
 
  
To test APTS-MT in the ConA-based assay, the assay concentrations were chosen to be 200 nM APTS-MT 
and 1 µM ConA according to the map in Figure 1A.  A range of concentrations of various 
monosaccharides were added to microplate wells with these final assay concentrations, and sufficient 
time was given to reach equilibrium prior to fluorescence anisotropy measurements.  The assay reached 
steady state in less than one minute.  The fluorescence anisotropy responses are shown in the semi-log 
plot of Figure 5B.  It is important to note that each data point is an independent assay in a unique 
microplate well.  The anisotropy responses show that the binding of the APTS-MT to ConA is effectively 
inhibited by monosaccharides that are known to only bind to the primary binding site of ConA (methyl-
ɲ-mannose and glucose).  In addition, high levels of the monosaccharides allow for the full reversal of 
ƚŚĞĞƋƵŝůŝďƌŝƵŵďŝŶĚŝŶŐ ?ĂƐŝŶĚŝĐĂƚĞĚďǇĂŶŝƐŽƚƌŽƉǇǀĂůƵĞƐƚŚĂƚĂƌĞĞƋƵĂůƚŽƚŚŽƐĞŝĨŽŶǁĂƐŶ ?ƚƉƌĞƐĞŶƚ
(Figure 5A). Methyl-ɲ-mannose is known to have a binding affinity that is ~20-40 times higher than 
glucose, and galactose shows no affinity to ConA (Mandal et al., 1994).  As a result, the relative 
responses to the monosaccharides were expected as described by the Cheng-Prusoff equation for 
competitive binding (Cheng and Prusoff 1973).  This set of results is highly encouraging and suggests 
that the APTS-MT ƚŚĂƚďŝŶĚƐƚŽŽŶ ?Ɛ ĨƵůůďŝŶĚŝŶŐƐŝƚĞis truly undergoing competitive binding with a 
monosaccharide that binds to the primary binding site alone.   
 
 
Figure 6: (A) Steady-state anisotropy of the 200 nM APTS-MT and 1 µM ConA assay to physiologically relevant glucose 
concentrations shown on a linear plot.  (B) The predicted glucose vs. actual glucose from the best fit of the 200 nM APTS-MT 
and 1 µM ConA assay.  
 
The assay was exposed to additional, physiologically-relevant glucose concentrations and displayed on 
the linear plot in Figure 6A.  This shows that the majority of the response occurs over the physiologically 
relevant glucose concentration range and is a direct result of the assay being designed to maximize the 
recognition mechanism.  While this response is fairly linear, a traditional competitive binding equation 
was used to fit the data that can be used to predict the glucose concentrations from the measured 
fluorescence anisotropy.   
The glucose concentrations were predicted with this fit from the anisotropy data and compared to the 
actual glucose data in Figure 6B.  This shows a standard error of calibration of 8.5 mg/dL and a mean 
absolute relative difference (MARD) of 6.5% across the physiologically relevant glucose concentrations.  
In comparison to the predicted vs. actual glucose concentration plot of the assay based on the 4 kDa 
FITC-dextran, the points using APTS-MT are much closer to the line depicting an ideal sensing assay.  The 
slight fluctuations are expected to be caused by pipetting error rather than error with the assay.     
 
 
Conclusions 
In summary, a rationally-designed fluorescent ligand was introduced for use in a ConA-based glucose 
sensing assay that used a new approach intended to avoid the aggregation problems that have 
traditionally plagued such assays.  By engineering the ligand to present a single high-affinity trimannose 
moiety that binds to the full binding site of ConA, the required high affinity can be reached without 
requiring multiple moieties that can lead to crosslinking with ConA.  A desirable fluorophore was 
introduced in a manner that left the entire trimannose moiety unaltered, and the glucose-dependent 
equilibrium binding of the rationally-designed fluorescent ligand was effectively tracked via fluorescence 
anisotropy.  This new approach to the design of the fluorescent ligand can potentially serve as a solution 
to the long-standing problems of ConA-based assays, and variants of this fluorescent ligand can be 
engineered for use in continuous glucose monitoring devices.   
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